Does adjuvant therapy for high-risk melanoma with either immunotherapy or targeted therapy affect therapeutic choices at relapse? [interview] Journal Article
| Author: | Postow, M. A. |
| Article Title: | Does adjuvant therapy for high-risk melanoma with either immunotherapy or targeted therapy affect therapeutic choices at relapse? [interview] |
| Journal Title: | Clinical Advances in Hematology & Oncology |
| Volume: | 16 |
| Issue: | 5 |
| ISSN: | 1543-0790 |
| Publisher: | Millennium Medical Publishing, Inc |
| Date Published: | 2018-05-01 |
| Start Page: | 353 |
| End Page: | 355 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 29851931 |
| DOI/URL: | |
| Notes: | Note -- Export Date: 2 July 2018 -- Source: Scopus |
